Summary (tl;dr)

Concerns are rising globally over a "super flu" variant, identified as Influenza A H3N2 subclade K, which is causing an earlier and potentially more severe flu season than usual, with the current vaccine offering a less-than-perfect match.

Essential Background

Seasonal influenza, commonly known as the flu, is an acute respiratory infection caused by influenza viruses that circulate globally each year. These viruses constantly evolve, requiring annual updates to vaccines. Typically, Northern Hemisphere flu seasons run from November to March, and Southern Hemisphere seasons from May to September, with human travel connecting the spread of dominant strains between hemispheres. For the 2025-2026 season, health organizations, including the CDC and WHO, have been monitoring influenza activity, especially given that the previous 2024-2025 season was classified as high severity.

The Full Story

A new variant of influenza A H3N2, known as subclade K, has emerged and is currently driving an early and intense flu season across several regions, leading to its colloquial designation as "super flu" in headlines. Detections of this subclade rapidly increased starting in August 2025, particularly in Australia and New Zealand, before spreading to Europe, the United Kingdom, and becoming the dominant strain in the United States. This variant has undergone significant genetic changes compared to the strain used in the 2025-2026 seasonal influenza vaccine, potentially reducing the vaccine's effectiveness. Health officials, including the CDC, report increasing flu activity across the United States, with 17 jurisdictions showing high or very high levels of influenza-like illness, and the subclade K accounting for approximately 90% of recent H3N2 cases. This rise in cases has led to school closures in some areas and hospital visitor restrictions.

Why It Matters

The emergence of the H3N2 subclade K is significant because H3N2-predominant flu seasons are historically associated with higher rates of hospitalization and death, especially among older adults and young children. While early estimates suggest the current vaccine still offers protection against severe illness and hospitalization, its effectiveness against the subclade K strain for preventing clinical disease may be reduced due to the genetic drift. This situation raises concerns about increased strain on healthcare systems and potentially a "very difficult flu season". Public health officials are urging vigilance for symptoms, recommending vaccination, and emphasizing prompt treatment with antiviral drugs, especially for high-risk individuals.

Geographic Location

• United Kingdom (early and severe flu season prompting "super flu" warnings)
• Europe (hit hard by the strain, with high or very high activity in many countries)
• Australia and New Zealand (initial detection and rapid increase of subclade K in August 2025)
• New York, United States (very high levels of flu)
• Rhode Island, United States (very high levels of flu)
• Colorado, United States (very high levels of flu)
• Louisiana, United States (very high levels of flu)
• Massachusetts, United States (spikes in flu activity)
• Florida, United States (rising flu cases, including Miami-Dade County)
• Bay Area, California, United States (increasing risk ahead of holidays, highest levels of influenza A in the state)
• Marin County, California, United States (schools closed due to flu-like symptoms)
• Detroit Medical Center, Wayne County, Michigan, United States (implemented visitor restrictions due to flu spread)
• Missouri, United States (schools closed due to high illness rates)
• Iowa, United States (schools closed due to high illness rates)